These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32306237)

  • 1. Dextrose-Containing Carrier Solution for Hyperthermic Intraperitoneal Chemotherapy: Increased Intraoperative Hyperglycemia and Postoperative Complications.
    Torphy RJ; Stewart C; Sharma P; Halpern AL; Oase K; Herter W; Bartsch C; Friedman C; Del Chiaro M; Schulick RD; Gleisner A; McCarter MD; Ahrendt SA
    Ann Surg Oncol; 2020 Dec; 27(13):4874-4882. PubMed ID: 32306237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.
    Stewart CL; Gleisner A; Halpern A; Ibrahim-Zada I; Luna RA; Pearlman N; Gajdos C; Edil B; McCarter M
    Ann Surg Oncol; 2018 Mar; 25(3):655-659. PubMed ID: 29204776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Perfusate Glucose Concentration on Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Lindsey PT; Martin RCG; Scoggins CR; Philips P; Marshall BM; Carter TS; Egger ME
    J Surg Res; 2020 Dec; 256():206-211. PubMed ID: 32711177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative hyperglycemia in patients undergoing cytoreductive surgery and HIPEC: A cohort study.
    DiSano JA; Wischhusen J; Schaefer EW; Dessureault S; Wong J; Soybel DI; Pameijer CR
    Int J Surg; 2019 Apr; 64():5-9. PubMed ID: 30772524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Intraoperative Systematic Bacterial Sampling During Complete Cytoreductive Surgery (CRS) with Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) Influence Postoperative Treatment? A New Predictive Factor for Postoperative Abdominal Infectious Complications.
    Dazza M; Schwarz L; Coget J; Frebourg N; Wood G; Huet E; Bridoux V; Veber B; Tuech JJ
    World J Surg; 2016 Dec; 40(12):3035-3043. PubMed ID: 27412631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion.
    Hendrix RJ; Damle A; Williams C; Harris A; Spanakis S; Lambert DH; Lambert LA
    Ann Surg Oncol; 2019 Feb; 26(2):490-496. PubMed ID: 30515670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
    Mehta AM; Huitema AD; Burger JW; Brandt-Kerkhof AR; van den Heuvel SF; Verwaal VJ
    Ann Surg Oncol; 2017 Apr; 24(4):990-997. PubMed ID: 27896510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
    Li XB; Ma R; Ji ZH; Lin YL; Zhang J; Yang ZR; Chen LF; Yan FC; Li Y
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):600-606. PubMed ID: 31973925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    van Vugt JL; Braam HJ; van Oudheusden TR; Vestering A; Bollen TL; Wiezer MJ; de Hingh IH; van Ramshorst B; Boerma D
    Ann Surg Oncol; 2015 Oct; 22(11):3625-31. PubMed ID: 25672564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
    van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
    Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.
    Downs-Canner S; Ding Y; Magge DR; Jones H; Ramalingam L; Zureikat A; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2015 May; 22(5):1651-7. PubMed ID: 25348781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Tan GHC; Chia CS; Tan SH; Soo KC; Teo MCC
    Int J Clin Oncol; 2018 Oct; 23(5):989-998. PubMed ID: 29869757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Dagbert F; Thievenaz R; Decullier E; Bakrin N; Cotte E; Rousset P; Vaudoyer D; Passot G; Glehen O
    Ann Surg Oncol; 2016 Jun; 23(6):1980-5. PubMed ID: 26913716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Baumgartner JM; Kwong TG; Ma GL; Messer K; Kelly KJ; Lowy AM
    Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors.
    Charrier T; Passot G; Peron J; Maurice C; Gocevska S; Quénet F; Eveno C; Pocard M; Goere D; Elias D; Ortega-Deballon P; Vaudoyer D; Cotte E; Glehen O
    Ann Surg Oncol; 2016 Jul; 23(7):2315-22. PubMed ID: 26920385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy.
    Cascales Campos P; Martinez Insfran LA; Wallace D; Gil J; Gil E; Gonzalez Gil A; Martínez J; Alonso Romero JL; Gonzalez Sanchez R; Parrilla P
    Clin Transl Oncol; 2020 Jun; 22(6):852-859. PubMed ID: 31392644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP Analysis.
    Paredes AZ; Guzman-Pruneda FA; Abdel-Misih S; Hays J; Dillhoff ME; Pawlik TM; Cloyd JM
    J Surg Res; 2019 Sep; 241():31-39. PubMed ID: 31004870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
    Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
    Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy.
    Mehta AM; Van den Hoven JM; Rosing H; Hillebrand MJ; Nuijen B; Huitema AD; Beijnen JH; Verwaal VJ
    Int J Pharm; 2015 Feb; 479(1):23-7. PubMed ID: 25535649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.